Complement Blockade Is a Promising Therapeutic Approach in a Subset of Critically Ill Adult Patients with Complement-Mediated Hemolytic Uremic Syndromes

Thrombotic microangiopathy (TMA) gathers consumptive thrombocytopenia, mechanical haemolytic anemia, and organ damage. Hemolytic uremic syndromes (HUS) are historically classified as primary or secondary to another disease once thrombotic thrombocytopenic purpura (TTP), Shiga-toxin HUS, and cobalami...

Descripción completa

Detalles Bibliográficos
Autores principales: Prével, Renaud, Delmas, Yahsou, Guillotin, Vivien, Gruson, Didier, Rivière, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837052/
https://www.ncbi.nlm.nih.gov/pubmed/35160242
http://dx.doi.org/10.3390/jcm11030790

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8837052/
https://www.ncbi.nlm.nih.gov/pubmed/35160242
http://dx.doi.org/10.3390/jcm11030790

Ejemplares similares